AIDS Drug Assistance Programs: Highlighting inequities in human immunodeficiency virus-infection health care in the United States

Clinical Infectious Diseases

Volumn 35, Issue 5, 2002, Pages 606-610

  Walensky, Rochelle P ^a,c   Paltiel, A David ^d   Freedberg, Kenneth A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD CENTER FOR RISK ANALYSIS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG COST; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE DISTRIBUTION; HEALTH CARE FINANCING; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAID; PATIENT CARE; PRIORITY JOURNAL; UNITED STATES; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMBULATORY CARE; COST-BENEFIT ANALYSIS; DRUG COSTS; FINANCIAL MANAGEMENT; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INSURANCE COVERAGE; MEDICAL ASSISTANCE; PHARMACEUTICAL SERVICES; STATE HEALTH PLANS; TREATMENT OUTCOME; UNITED STATES;

EID: 0036721502     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/341903     Document Type: Article

References (31)

1. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. HIV Cost and Services Utilization Study
2. The cost effectiveness of combination antiretroviral therapy for HIV disease
3. Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel
4. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
5. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
6. Rationing HIV medications: What do patients and the public think about allocation policies?
7. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons
8. State AIDS drug assistance programs (ADAPs): Equity and efficiency in an era of rapidly changing treatment standards
9. Costs of hepatitis C
10. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
11. Resource utilization in liver transplantation: Effects of patient characteristics and clinical practice
12. Equity in health in unequal societies: Meeting health needs in contexts of social change
13. Principles of justice in health care rationing
14. Ability to obtain medical care for the uninsured: How much does it vary across communities?
15. Unmet health needs of uninsured adults in the United States
16. Cost-effectiveness of HIV screening in acute care settings
17. The cost-effectiveness of preventing AIDS-related opportunistic infections
18. Long-term impact of highly active antiretroviral therapy on HIV-related health care costs
19. Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness
20. Cost effectiveness of combination HIV therapy: 3 Years later
21. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
22. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults
23. President's budget proposes increases for NIH, cuts for CDC, HRSA and AHRQ